Announced Mon, 29 Jun · 12:14 IST
Trading window closed from July 1 for Q1 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹33.36
prior close
₹33.36
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.8-4.8-10.2-13.1-8.7-8.9-10.1———
Up moveDown movePending
AI summary
Genomic Valley Biotech has closed its trading window from July 1, 2026 until 48 hours after the announcement of unaudited financial results for the quarter ended June 30, 2026. During this period, employees, directors, key managerial personnel, designated persons and their immediate relatives cannot trade in the company's shares. The board meeting date for declaring results will be announced later.
Likely market impact
Routine compliance announcement under SEBI insider trading rules. Signals upcoming Q1 FY27 results but no direct impact on shareholders.